Sandostatin Lar (Octreotide)

Sandostatin Lar is a medication containing octreotide, used for managing symptoms related to certain hormonal imbalances. This intramuscular injection is designed for long-term use and is manufactured by Novartis Europharm Limited.

Sandostatin Lar is primarily used to control symptoms associated with acromegaly, a condition where the body produces too much growth hormone. It may also be used to manage symptoms of certain tumors that release excessive hormones, such as carcinoid tumors. Octreotide, the active ingredient, helps to regulate hormone levels and alleviate related symptoms.

Common effects of Sandostatin Lar may include injection site reactions, nausea, and abdominal pain. Some individuals might experience changes in blood sugar levels or digestive issues. These effects can vary and are not experienced by everyone.

Sandostatin Lar should be used under medical supervision. It is important to inform your healthcare provider about any allergies or other medications you are taking. This medication should be stored and handled according to the guidelines provided by the manufacturer to ensure its effectiveness and safety.

Sandostatin Lar may interact with other medications, including those that affect blood sugar levels or are metabolized by the liver. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain foods may also influence the effects of this medication.